Keyphrases
Statins
100%
Confidence Interval
100%
Odds Ratio
100%
Extrahepatic Cholangiocarcinoma
100%
Distal Cholangiocarcinoma
71%
Perihilar Cholangiocarcinoma
42%
Significant Risk Factors
28%
Statin Use
28%
Hazard Ratio
28%
Mayo Clinic
14%
Cell Division
14%
Risk Reduction
14%
Inflammatory Bowel Disease
14%
AIMS™
14%
Rochester
14%
Cancer Risk
14%
Residency
14%
Validation Studies
14%
Cancer Development
14%
Race-ethnicity
14%
Apoptosis
14%
Cirrhosis
14%
Hepatitis C Virus Infection
14%
Liver Disease
14%
Moderate Intensity
14%
Cancer-specific Survival
14%
Risk Ratio
14%
Human Cholangiocarcinoma
14%
Cholangiocarcinoma Cells
14%
Bile Duct Stone Disease
14%
Nursing and Health Professions
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
100%
Bile Duct Carcinoma
100%
Odds Ratio
46%
Confidence Interval
46%
Statin (Protein)
26%
Hazard Ratio
13%
Hyperlipidemia
13%
Case-Control Study
6%
Malignant Neoplasm
6%
Liver Cirrhosis
6%
Inflammatory Bowel Disease
6%
Liver Disease
6%
Hepatitis C
6%
Diseases
6%
Medicine and Dentistry
Statin
100%
Cholangiocarcinoma
100%
Odds Ratio
46%
Hyperlipidemia
13%
Hazard Ratio
13%
Malignant Neoplasm
6%
Programmed Cell Death
6%
Inflammatory Bowel Disease
6%
Hepatitis C
6%
Cell Division
6%
Liver Cirrhosis
6%
Liver Disease
6%
Case-Control Study
6%
Biliary Stone Disease
6%
Pharmacology, Toxicology and Pharmaceutical Science
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
100%
Bile Duct Carcinoma
100%
Statin (Protein)
26%
Hyperlipidemia
13%
Case-Control Study
6%
Malignant Neoplasm
6%
Inflammatory Bowel Disease
6%
Liver Disease
6%
Liver Cirrhosis
6%
Hepatitis C
6%
Diseases
6%